Some hedge fund models assess "LEU stock forecast 2025" with Monte Carlo simulations to capture uranium demand variance, often landing median price points near $ Novo is looking for new drug candidates to secure future growth. Its patent for the active ingredient in Wegovy and Ozempic expires by 2032 in the United States. Find detailed analytics on LEU stock on TipRanksâ Stock Analysis page . Quantitative screens rank "LEU stock forecast 2025" favorably versus peers on return-on-equity metrics above 20%, supported by lean operational costs and specialized technology licensing advantages.